Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Boehringer Ingelheim
Federal Trade Commission
Colorcon
Johnson and Johnson
UBS
AstraZeneca
Citi
Harvard Business School

Generated: July 22, 2018

DrugPatentWatch Database Preview

Dextrose; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium acetate - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for dextrose; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium acetate and what is the scope of dextrose; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium acetate patent protection?

Dextrose; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium acetate
is the generic ingredient in two branded drugs marketed by B Braun and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for dextrose; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium acetate. One supplier is listed for this compound.
Summary for dextrose; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium acetate

US Patents and Regulatory Information for dextrose; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium acetate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun ISOLYTE P W/ DEXTROSE 5% IN PLASTIC CONTAINER dextrose; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium acetate INJECTABLE;INJECTION 019025-001 Dec 27, 1984 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
B Braun ISOLYTE P IN DEXTROSE 5% IN PLASTIC CONTAINER dextrose; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium acetate INJECTABLE;INJECTION 019873-001 Jun 10, 1993 RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Teva
Harvard Business School
Deloitte
Moodys
Mallinckrodt
Chinese Patent Office
Daiichi Sankyo
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.